Diabetic Retinopathy

Diabetic retinopathy is a complication from diabetes that affects the eyes. It sometimes leads to partial vision loss and eventually results in blindness. The leading cause of blindness in adults, diabetic retinopathy is caused by damage to or swelling of the blood vessels in the back of the eye (the retina), which is constructed of light-sensitive tissue. In some cases, blood vessels can leak fluid into the eye's macula causing blurred vision. In other cases, new blood vessels grow abnormally, attaching to the surface of the retina. Anyone with type 1 or type 2 diabetes is at risk but especially longtime diabetics and those with less controlled blood sugar levels.

Why UAB

The specialists at UAB Callahan Eye Hospital use the most advanced technology and are known for working together to treat the full range of both common and complex corneal problems. From cataract and corneal surgeries to highly specialized contact lenses, Callahan features the expertise, experience, and cutting-edge equipment needed to treat the most challenging corneal conditions. Patients come here from around the world and nation because we don’t just treat eye disease – we empower patients to take control of their eye health.

Callahan is the only full-service facility in Alabama specializing in the diagnosis and treatment of the eye and one of only a few worldwide that is entirely devoted to advancements in ophthalmology. That reputation is supported by 16 operating rooms dedicated to eye surgery and a 24/7 eye emergency room that is the region’s only Level I Ocular Trauma Center. More than 11,000 surgeries are performed at UAB Callahan Eye Hospital each year, and we conduct more reconstructive eye procedures than any other facility in the world.

Our facility is home to more than two dozen ophthalmologists, many of whom are named among the top doctors in their fields nationally. Callahan is widely recognized for excellence in patient care, having consistently earned prestigious awards from health care consulting group Press Ganey, and in 2017 Callahan was named as one of the “100 Great Places to Work in Healthcare” by Becker’s Hospital Review.

Callahan also is known for pioneering developments in surgical instruments, devices, and procedures used by ophthalmologists across the globe. As part of the UAB Medicine academic medical center, Callahan is actively involved in ongoing research and clinical trials. Many of our ophthalmologists have received funding from prestigious research organizations and institutions and collaborate in clinical care to bring the latest in scientific discovery to our patients.

VIDEOS

Priscilla Fowler, MD Assistant Professor and Director of the Cornea Service in the Department of Ophthalmology at UAB, discusses how easily "red eye" can be misdiagnosed.

UAB pilot program brings glaucoma screenings closer to home.

UAB Callahan Eye Hospital helped save a young baseball player’s career and, most importantly, his sight.


CARE PROVIDERS

J. Waid Blackstone, MD
J. Waid Blackstone, MD
Jeff Chaiprakob, MD
Jeff Chaiprakob, MD
Priscilla G. Fowler, MD
Priscilla G. Fowler, MD
Virginia R. Lolley, MD
Virginia R. Lolley, MD
John Morgan, MD
John Morgan, MD
Jeffrey Tapley, Jr., MD
Jeffrey Tapley, Jr., MD

RELATED SERVICES

CLINICAL TRIALS

UAB is an active participant in research and clinical trials for the diagnosis and treatment of diabetic retinopathy. We encourage you to speak to your physician about research and clinical trial options and browse the link below for more information.

View Clinical Trials